KFA
LLY icon

Krane Funds Advisors’s Eli Lilly LLY Stock Holding History

Krane Funds Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-438
Closed -$388K – 116
2024
Q3 		$388K Buy
438
+19
+5% +$17.1K 0.01% 65
2024
Q2 		$379K Buy
+419
New +$335K 0.02% 69
2022
Q2 		– Sell
-786
Closed -$225K – 326
2022
Q1 		$225K Sell
786
-1,642
-68% -$423K 0.01% 277
2021
Q4 		$671K Buy
2,428
+556
+30% +$141K 0.02% 131
2021
Q3 		$433K Buy
1,872
+464
+33% +$115K 0.01% 168
2021
Q2 		$323K Buy
+1,408
New +$283K 0.01% 271
2021
Q1 		– Sell
-1,562
Closed -$264K – 324
2020
Q4 		$264K Buy
+1,562
New +$233K 0.01% 245

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Krane Funds Advisors's LLY Position: Q4 2024 in Review

Krane Funds Advisors sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 438 shares — an estimated $388K sold.

Krane Funds Advisors first reported a position in LLY in Q4 2020 and held it in 7 quarters. The position peaked at $671K in Q4 2021. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Krane Funds Advisors reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Krane Funds Advisors sold 438 Eli Lilly shares in Q4 2024, an estimated $388K.
  • Krane Funds Advisors first reported a position in Eli Lilly in Q4 2020 and held it in 7 quarters.
  • Krane Funds Advisors's Eli Lilly position peaked at $671K in Q4 2021.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Krane Funds Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.